Warm Autoimmune vs. Drug-Induced Immune Hemolytic Anemia

Learn the keys to delivering the right hemolytic anemia diagnosis.

Nov 13, 2019

Duration: 26 minutes

Drug-induced immune hemolytic anemia (DIIHA) occurs when a drug triggers the immune system which causes red blood cells to hemolyze. By identifying DIIHA, the physician may discontinue use of the drug causing the problem and take steps to prevent prescribing it in the future.

Disclosures: This promotional educational activity is brought to you by Ortho Clinical Diagnostics and is not certified for Continuing Medical Education (CME). The speakers are presenting on behalf of Ortho Clinical Diagnostics and must present information in accordance with applicable and/or local regulatory country requirements.

About Our Speaker:
About Our Speaker:

Susan T. Johnson, MSTM, MT(ASCP)SBB

Director, Clinical Education, BloodCenter of Wisconsin; Director, Transfusion Medicine Program Marquette University